Adaobi Kanu is a Respiratory physician affiliated with Texas Tech University. OpenAlex indexes 8 publications with 280 citations (h-index 5); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4102 24th St Ste 507
Lubbock, TX 79410
Telephone
806-743-7334Provider last certified this registry record 3 Dec 2021.
Clinical trials
- Use of High Frequency Chest Compression in Pediatric Status Asthmaticus
Sponsor: Texas Tech University Health Sciences Center
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
29 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- AstraZeneca Pharmaceuticals LPProgram year20255 payments
- ARS Pharmaceuticals Operations, Inc.Program year20251 payment
- Insmed, Inc.Program year20253 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
40%beta2-Adrenergic Agonist11.4%Albuterol Sulfate Hfa100%Part D<11 patientsOther respiratory system products11.4%Trikafta100%Part D<11 patients+ 2 more classes in this area
Nervous system
27.1%Opioid Agonist10%Oxycodone Hcl100%Part D<11 patientsBenzodiazepine8.6%Alprazolam100%Part D<11 patients+ 1 more class in this area
Metabolism & gastrointestinal
12.1%Osmotic Laxative12.1%Lactulose100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Prevalence of Bactericidal/Permeability-Increasing Protein Autoantibodies in Cystic Fibrosis Patients: Systematic Review and Meta-Analysis
Pediatric Allergy Immunology and Pulmonology
2019 - Prevalence of urinary tract infection among HIV patients in Aba, Nigeria
International Journal of Infectious Diseases
2016
Similar KOLs
Other experts from the same institution or the same specialty.
Debabrata Mukherjee, MD
Texas Tech University
Ariwan Rakvit, MD
Texas Tech University
Biff Palmer, MD
Texas Tech University
Kenneth Nugent, MD
Texas Tech University
Fernando Martinez, MD
University of Massachusetts Chan Medical School
David Gozal, MD
Ronald Crystal, MD
Weill Cornell Medicine
Bartolome Celli, MD
Brigham and Women's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”